Based on these and previous findings (Borroto-Escuela et al., 2012) the hypothesis was tested if disturbances in the combined receptor agonist regulation of FGFR1-5-HT1A heteroreceptor complexes can take place at the behavioral and neurochemical levels in an animal model of depression. The gene discussed is FGFR1; the disease is depressive symptom measurement.